Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies

Alexis C. Boulter, Barry J. Maurer, Meredith Pogue, Min H. Kang, Hwangeui Cho, Amanda Knight, C. Patrick Reynolds, Donald Quick, Sanjay Awasthi, David E. Gerber

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds